Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada

[1] Cooper C(1997)The crippling consequences of fractures and their impact on quality of life Am J Med. 103 12S-7S

[2] Morin S(2011)Mortality rates after incident non-traumatic fractures in older men and women Osteoporos Int. 22 2439-48

[3] Lix LM(2021)Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario BMC Musculoskelet Disord 22 105-32

[4] Azimaee M(2016)The current economic burden of illness of osteoporosis in Canada Osteoporos Int. 27 3023-32

[5] Metge C(2021)A scorecard for osteoporosis in Canada and seven Canadian provinces Osteoporos Int. 32 123-102

[6] Caetano P(2009)Clinical subsequent fractures cluster in time after first fractures Ann Rheum Dis 68 99-46

[7] Leslie WD(2020)American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update Endocr Pract. 26 1-1622

[8] Brown JP(2019)Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 104 1595-12

[9] Adachi JD(2020)Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures Osteoporos Int. 31 1-1873

[10] Schemitsch E(2021)Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada BMC Musculoskelet Disord 22 224-9

[1] Cooper C(1997)The crippling consequences of fractures and their impact on quality of life Am J Med. 103 12S-7S

[2] Morin S(2011)Mortality rates after incident non-traumatic fractures in older men and women Osteoporos Int. 22 2439-48

[3] Lix LM(2021)Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario BMC Musculoskelet Disord 22 105-32

[4] Azimaee M(2016)The current economic burden of illness of osteoporosis in Canada Osteoporos Int. 27 3023-32

[5] Metge C(2021)A scorecard for osteoporosis in Canada and seven Canadian provinces Osteoporos Int. 32 123-102

[6] Caetano P(2009)Clinical subsequent fractures cluster in time after first fractures Ann Rheum Dis 68 99-46

[7] Leslie WD(2020)American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update Endocr Pract. 26 1-1622

[8] Brown JP(2019)Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 104 1595-12

[9] Adachi JD(2020)Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures Osteoporos Int. 31 1-1873

[10] Schemitsch E(2021)Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada BMC Musculoskelet Disord 22 224-9